Medical Xpress·3 min read·medium
Cutting-edge drug shows promise for patients with NRAS-driven melanoma
H
Huntsman Cancer Institute
✦AI Summary
Researchers at the Huntsman Cancer Institute have identified a potential new treatment for NRAS-driven melanoma using the drug daraxonrasib. Preclinical trials showed significant tumor shrinkage, offering hope for patients with this aggressive form of skin cancer.
edited by Swati Mestri , reviewed by Andrew Zinin
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in